Possible pharmacological target(s) identified in pediatric obstructive sleep apnea

Children with obstructive sleep apnea (OSA) may one day be able to have an injection or use a throat spray instead of getting their tonsils removed to cure their snoring, according to a new study which found that a specific gene product may be responsible for the proliferation of adenotonsillar tissue that can cause pediatric OSA.

Read the whole article on Science Daily

More from Science Daily